– Interview with William Frey, Co-Director, Alzheimer’s Research Center, Regions Hospital, St. Paul, MN, and Professor, Oral Biology and Pharmaceutics, University of Minnesota

Previous articleBioWa Grants Merck KGaA Access to Technology that Enhances Antibody-Dependent Cellular Cytotoxicity
Next articleAlnylam and Novartis Take RNAi Therapeutics Collaboration into Fifth Year